Tangen Biosciences Awarded Expanded Second Phase of Contract

Image: The first phase of the contract commenced in October 2017 and was valued at $3.2 million. Photo: Courtesy of Belova59 from Pixabay.



Related Article
Recommended Whitepaper

View More